Navigating the Current Drug Exclusivity Landscape: Implementing Strategies for Effective Patent Lifecycle Management Amidst New Pharmaceutical Law Reform in Europe
Christian Fulda
Partner
Jones Day
Hiroshi Sheraton
Partner
Baker & McKenzie LLP
- Assessing the latest developments in loss of exclusivity and incorporating those developments into your patent lifecycle management strategy
- Strategies for managing data exclusivity, market protection, orphan drug exclusivity, pediatric extensions/pediatric rewards
- Analyzing how the new Pharma Law revisions by the European Commission will impact regulatory exclusivity protections available to innovator pharmaceutical companies operating in the EU
- Understanding how to effectively achieve market exclusivity and protection of clinical trial data to best safeguard your (or your client’s) investment